TITLE

Predictors and Outcome of Readmission after Laparoscopic Intestinal Surgery

AUTHOR(S)
O'Brien, David; Senagore, Anthony; Merlino, James; Brady, Karen; Delaney, Conor
PUB. DATE
December 2007
SOURCE
World Journal of Surgery;Dec2007, Vol. 31 Issue 12, p2430
SOURCE TYPE
Academic Journal
DOC. TYPE
Correction notice
ABSTRACT
The original version of this article, published online on September 25, 2007 and in print in the November 2007 issue (vol 31/no 11, pp 2138–2143), did not include the full list of authors’ names. The correct list of authors and their affiliations are shown below. The article is reprinted in its entirety. Previous studies have failed to identify predictors of early readmission after major intestinal operations. The objectives of this study were to determine readmission rates, outcomes, and predictors of readmission for patients undergoing laparoscopic colon and rectal operations. Patients readmitted (PR) to the hospital within 30 days of discharge after laparoscopic colon and rectal operations were identified from a prospectively maintained database. The PR group was compared with patients that were not readmitted (NR). Outcomes and variables related to readmission were evaluated. There were 820 consecutive elective laparoscopic colon and rectal operations performed over a 5-year period, with adequate follow-up data for 787 cases. Seventy-nine (10%) patients were readmitted. There was no difference in the age, sex, surgeon, or type of operation between the PR and NR groups. The most common causes for readmission were bowel obstruction (19%), ileus (18%), intra-abdominal abscess (14%), and anastomotic leak (9%). Overall mean (median) length of stay (LOS) for the index admission was 3.7 ± 4.3 (3.0) days. Patients in the PR group had a trend toward a longer index admission LOS than the NR group (5.4 ± 8.8 [3.0] versus 3.5 ± 3.3 [3.0], p = 0.068). Univariate analysis demonstrated that patients with inflammatory bowel disease, pulmonary comorbidities, and steroid use were more likely to be readmitted. Multivariate analysis confirmed that inflammatory bowel disease and pulmonary comorbidity are independent risk factors for readmission. Early readmission after laparoscopic colon and rectal operations is not associated with early discharge. Identification of specific patient characteristics indicating risk for early readmission may allow for selective changes in perioperative care or discharge criteria to avoid unexpected readmission.
ACCESSION #
27734049

 

Related Articles

  • Varicella zoster virus infection in inflammatory bowel disease.  // Inflammatory Bowel Disease Monitor;2012, Vol. 12 Issue 4, p154 

    The authors discuss the study that examines the impact of varicella zoster infection in patients with inflammatory bowel diseases (IBD). They state that the philosophy of good overall IBD care practice has been epitomized by organizing vaccination to reduce or prevent the risk of infection while...

  • Isotretinoin and Risk of Inflammatory Bowel Disease: A French Nationwide Study. Racine, Antoine; Cuerq, Anne; Bijon, Anne; Ricordeau, Philippe; Weill, Alain; Allemand, Hubert; Chosidow, Olivier; Boutron-Ruault, Marie-Christine; Carbonnel, Franck // American Journal of Gastroenterology;Apr2014, Vol. 109 Issue 4, p563 

    OBJECTIVES:Isotretinoin, a drug widely prescribed for severe acne, has been suspected to increase the risk of ulcerative colitis (UC), but data are conflicting. To further examine the association between isotretinoin use and risk for UC and Crohn's disease (CD), we conducted a large nationwide...

  • An Envirogenomic Signature Is Associated with Risk of IBD-Related Surgery in a Population-Based Crohn's Disease Cohort. Nasir, Bushra; Griffiths, Lyn; Nasir, Aslam; Roberts, Rebecca; Barclay, Murray; Gearry, Richard; Lea, Rodney // Journal of Gastrointestinal Surgery;Sep2013, Vol. 17 Issue 9, p1643 

    Background and Aims: Crohn's disease (CD) is an inflammatory bowel disease (IBD) caused by a combination of genetic, clinical, and environmental factors. Identification of CD patients at high risk of requiring surgery may assist clinicians to decide on a top-down or step-up treatment approach....

  • Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.  // Gastroenterology & Hepatology;Sep2012, Vol. 8 Issue 9, p615 

    An interview with physician David G. Pinion about Clostridium difficile infection in patients with inflammatory bowel disease, is presented. He describes the burden of disease associated with Clostridium difficile infection in the general population, as well as to those with inflammatory bowel...

  • Osteoporosis in adult Sri Lankan inflammatory bowel disease patients. de Silva, Arjuna Priyadarsin; Karunanayake, Aranjan Lionel; Dissanayaka, Thalahitiya Gamaralalage Iruka; Dassanayake, Anuradha Supun; Duminda, Hewa Kattadi Kankanamgae Tilak; Pathmeswaran, Arunasalam; Wickramasinghe, Ananda Rajitha; de Silva, Hithanadura Janaka; Koutroubakis, Ioannis E. // World Journal of Gastroenterology;7/28/2009, Vol. 15 Issue 28, p3528 

    AIM: To determine if inflammatory bowel disease (IBD) is a risk factor for osteoporosis in adult Sri Lankans. METHODS: We identified eligible subjects from among consecutive patients diagnosed with IBD who attended our outpatient clinic. We included only patients aged between 20 and 70 years....

  • Periodicity of Hospital Admissions for Inflammatory Bowel Disease. Sonnenberg, Amnon; Jacobsen, Steven J.; Wasserman, Irene H. // American Journal of Gastroenterology;Jun1994, Vol. 89 Issue 6, p847 

    Objectives: It bas been speculated that exacerbations of inflammatory bowel disease are influenced by seasonal variations. Methods: This hypothesis was tested in a large data base of the Health Care Financing Administration (HCFA), consisting of all hospitalized US Medicare beneficiaries from...

  • Optimal Timing of Surgery for Inflammatory Bowel Diseases. Hodin, Richard S. // Journal of Gastrointestinal Surgery;Dec2008, Vol. 12 Issue 12, p2149 

    The article discusses reports on optimal timing of surgery for inflammatory bowel disease (IBD) patients.

  • Genetics versus environment in inflammatory bowel disease: Results of a British twin study. Thompson, Nick P.; Driscoll, Richard // BMJ: British Medical Journal (International Edition);1/13/96, Vol. 312 Issue 7023, p95 

    Presents the results of a study aimed at determining the levels of concordance for inflammatory bowel disease in British twin pairs. Genetic component to the cause of inflammatory bowel disease; Concordance rates; Determination of zygosity in the study.

  • Corrigendum: Genetic Analysis in A Dutch Study Sample Identifies More Ulcerative Colitis Susceptibility Loci and Shows Their Additive Role in Disease Risk. Festen, Eleonora A. M.; Stokkers, Pieter C. F.; van Diemen, Cleo C.; van Bodegraven, Adriaan A.; Boezen, H. Marieke; Crusius, Bart J. A.; Hommes, Daniel W.; van der Woude, Janneke C.; Balschun, Tobias; Verspaget, Hein W.; Schreiber, Stephan; de Jong, Dirk J.; Franke, Andre; Dijkstra, Gerard; Wijmenga, Cisca; Weersma, Rinse K. // American Journal of Gastroenterology;Feb2010, Vol. 105 Issue 2, p479 

    A correction to the article "Genetic Analysis in A Dutch Study Sample Identifi es More Ulcerative Colitis Susceptibility Loci and Shows Their Additive Role in Disease Risk" that was published in the previous issue is presented.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics